Mercedes Ferrer Selected Research

Hypoglycemic Agents (Hypoglycemics)

1/2020	Regular insulin added to total parenteral nutrition vs subcutaneous glargine in non-critically ill diabetic inpatients, a multicenter randomized clinical trial: INSUPAR trial.
10/2013	Modification of cardiometabolic profile in obese diabetic patients after bariatric surgery: changes in cardiovascular risk.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mercedes Ferrer Research Topics

Disease

5	Hypertension (High Blood Pressure) 01/2021 - 09/2007
4	Cardiovascular Diseases (Cardiovascular Disease) 12/2021 - 01/2015
4	Hyperglycemia 06/2020 - 05/2013
3	Hypoglycemia (Reactive Hypoglycemia) 06/2020 - 01/2015
2	Type 2 Diabetes Mellitus (MODY) 06/2020 - 10/2013
2	Diabetes Mellitus 06/2020 - 10/2013
2	Critical Illness (Critically Ill) 01/2020 - 05/2013
1	Inflammation (Inflammations) 01/2021
1	Prostatic Neoplasms (Prostate Cancer) 01/2021
1	Neoplasms (Cancer) 01/2018
1	Atherosclerosis 01/2018
1	Abdominal Aortic Aneurysm 01/2018
1	Prediabetic State (Prediabetes) 01/2015
1	Portal Hypertension 09/2009

Drug/Important Bio-Agent (IBA)

5	Insulin (Novolin)FDA Link 06/2020 - 05/2013
3	Testosterone (Sustanon)FDA Link 01/2021 - 01/2017
3	Blood Glucose (Blood Sugar)IBA 01/2015 - 05/2013
2	Calcitonin Gene-Related PeptideIBA 01/2021 - 04/2009
2	AndrogensIBA 01/2021 - 01/2017
2	Antihypertensive Agents (Antihypertensives)IBA 01/2021 - 01/2017
2	C-Reactive ProteinIBA 01/2021 - 05/2013
2	Norepinephrine (Noradrenaline)FDA LinkGeneric 01/2021 - 04/2009
2	ProstaglandinsIBA 01/2021 - 09/2009
2	Thromboxane A2 (A2, Thromboxane)IBA 01/2021 - 01/2018
2	Insulin Glargine (Lantus)FDA Link 06/2020 - 01/2020
2	LipidsIBA 06/2020 - 05/2013
2	CarbohydratesIBA 06/2020 - 05/2013
2	Hypoglycemic Agents (Hypoglycemics)IBA 01/2020 - 10/2013
2	Glucose (Dextrose)FDA LinkGeneric 01/2020 - 01/2015
1	Fatty Acids (Saturated Fatty Acids)IBA 12/2021
1	Neurotransmitter Agents (Neurotransmitter)IBA 01/2021
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2021
1	15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic AcidIBA 01/2021
1	Urea (Carbamide)FDA LinkGeneric 06/2020
1	ApolipoproteinsIBA 01/2018
1	Angiotensin IIIBA 01/2018
1	Serine (L-Serine)FDA Link 01/2018
1	Apolipoproteins E (ApoE)IBA 01/2018
1	TESIBA 01/2017
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 01/2015
1	SteroidsIBA 05/2013
1	AlbuminsIBA 05/2013
1	Amino Acids FDA Link 05/2013
1	Acetylcholine (Acetylcholine Chloride)FDA Link 09/2009
1	Epoprostenol (Prostacyclin)FDA LinkGeneric 09/2009
1	salicylhydroxamic acid (SHAM)IBA 09/2009
1	Vasodilator Agents (Vasodilators)IBA 09/2009
1	ColforsinIBA 09/2009
1	Adrenergic Agents (Adrenergic Drugs)IBA 04/2009
1	Adenosine Triphosphate (ATP)IBA 06/2008
1	Potassium Channels (Potassium Channel)IBA 06/2008
1	KATP ChannelsIBA 06/2008
1	Dexamethasone (Maxidex)FDA LinkGeneric 09/2007

Therapy/Procedure

5	Total Parenteral Nutrition 06/2020 - 05/2013
4	Therapeutics 01/2021 - 05/2013
3	Parenteral Nutrition 06/2020 - 05/2013
1	Orchiectomy (Orchidectomy) 01/2017
1	Length of Stay 01/2015
1	Gastric Bypass (Roux-en-Y Gastric Bypass) 10/2013
1	Ligation 09/2009